Cannabidiol (CBD) has been having a magnificent run for the past couple of years. The cannabis extract is, without a doubt, one of the most versatile and potent naturally-occurring medicines we’ve encountered in decades, if not centuries. Said to be effective against a variety of medical conditions ranging from high blood pressure to chronic pain and childhood epilepsy, CBD has been subject to intense interest over the years.
Naturally, a plant with such diverse medical benefits couldn’t be slept on for too long. The 2018 Farm Bill termed cannabis with less than 0.3 THC as industrial hemp, making its cultivation, marketing, and sale legal. This was followed by the USDA’s interim rule on hemp in October 2019, further rounding out the sector’s regulations. The result was an influx of supply, with everyone from hemp farmers to CBD processors looking to cash in on…
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.